ABSTRACT The beryllium lymphocyte transformation test was performed on 16 patients with chronic beryllium disease, 10 subjects (seven patients and three young boys) who were under suspicion, and 117 healthy beryllium workers. The tests gave a positive response in all patients with definite disease and a negative response in the suspected group. Two of the healthy workers had a positive response, indicating both exposure and sensitisation. It is not known whether sensitised workers are more liable to develop disease. We consider that the test is of value in the diagnosis of beryllium disease and advocate its use in monitoring the health of potentially exposed workers.
Introduction
We have continued our studies on the value of in vitro beryllium hypersensitivity tests in the diagnosis of disease and health monitoring in potentially exposed workers. The diagnosis of chronic beryllium disease is difficult as it is often impracticable to satisfy all the diagnostic criteria. ' It is essential to obtain evidence of exposure to beryllium as consistent clinical and radiographic features and detection by biopsy of epithelioid cell granulomas do not always distinguish chronic beryllium disease from sarcoidosis. The detection of beryllium in urine or tissue is an index of exposure and not of disease. Although beryllium hypersensitivity is commonly found in association with beryllium disease, it has yet to be determined whether in healthy beryllium workers it is an index of increased susceptibility. It may be inadvisable to perform beryllium patch tests for fear of exacerbating existing disease2 or initiating hypersensitivity in non-sensitised workers. Much interest has therefore been shown in the use of in vitro hypersensitivity tests.3-"
We have previously shown'0 that the beryllium lymphocyte transformation test is a more reliable method for detecting beryllium hypersensitivity than the macrophage migration inhibition test. The former was positive in all seven patients tested irrespective of steroid treatment, negative in 72 healthy beryllium workers, and reproducible on repeat testing. In contrast, the result of the macrophage migration inhibition test was positive in only four of the seven patients and was positive in four of the 72 healthy workers, and results were not reproducible. Marx We consider that a stimulation index of more than 2*0 indicates hypersensitivity, on the basis of common usage and the fact that all our patients showed values in excess of this figure.
Subjects PATIENTS WITH CHRONIC BERYLLIUM DISEASE
The group consisted of 14 men and two women aged from 38 to 68 years (mean 56 + 8-8 years). Twelve had been concerned with beryllium alloy work and four with ceramic manufacture for periods ranging from three weeks to 29 years (mean 10 + 7.8 years). All had consistent clinical or radiographic features (or both) of the disease, with pulmonary lesions. Twelve of the 14 had positive histological findings. Beryllium was found in the urine of two of the eight tested and in tissue from one of three. Four of seven tested gave a positive response in the beryllium patch test. Nine were having steroid treatment at the time of testing.
SUBJECTS UNDER SUSPICION OF CHRONIC BERYLLIUM DISEASE
All the ten subjects in the second group had been potentially exposed to beryllium with the possibility of developing disease. Two were beryllium and alloy machinists. Two fitters and one slip caster worked in a ceramic factory. Two men handled only finished products, with occasional visits to a beryllium machine shop. Three young boys had been accidentally exposed to drums contaminated with beryllium oxide.
None had conclusive evidence of beryllium disease. With the exception of the three boys all had consistent evidence of respiratory disease. One patient (case 1) had a biopsy that showed pulmonary sarcoid-type granulomas. The results of urine tests were negative for beryllium in all five subjects examined (cases 1, 4, 8, 9, 10). Four were clinically diagnosed as having idiopathic pulmonary fibrosis, one sarcoidosis, and two chronic bronchitis.
An additional patient, a metallurgical chemist aged 54, with potential but not proved exposure, who had worked with various metals and alloys, was also tested. He presented with progressive dyspnoea and increasing radiographic evidence of fibrosis. Precipitin tests for a large variety of antigens (Candida; Aspergillus; budgerigar, pigeon, and chicken extracts; and Micropolyspora faeni) all gave a negative response. Lung biopsy showed interstitial fibrosis and sarcoid-type granulomas. Value of beryllium lymphocyte transformation tests tLater proved at necropsy to be rheumatoid lung disease. We have previously shown'0 that the beryllium lymphocyte transformation test using 20% serum gave a positive result in all our patients with chronic beryllium disease, but with 10% serum the rate dropped to 50%. Possibly therefore we are underestimating the positive rate in the beryllium workers examined. Though the two workers with positive responses were indistinguishable from the others, the test showed that they had become sensitised to beryllium. Whether they are at increased risk of developing chronic beryllium disease remains to be seen. They and any other positive responders detected in the future will therefore be carefully monitored clinically and radiographically and by urine analysis. These two workers also illustrate a potential environmental hazard. The development of beryllium sensitisation proves an occupational exposure as it is extremely unlikely that these men would have been exposed elsewhere. Our test therefore is an indirect index of industrial hygiene. These findings would be even more useful if workers underwent a beryllium lymphocyte transformation test at the time of first employment, when it would be expected that all would give a negative result. Subsequent development of beryllium sensitisation would thus prove exposure.
We have shown, firstly, that all patients with chronic beryllium disease are sensitised to beryllium and thus the beryllium lymphocyte transformation test is of value in diagnosing the disease and, secondly, that a few healthy beryllium workers become sensitised to beryllium. Further work is required to determine whether sensitised workers are at increased risk of developing chronic beryllium disease.
